Under ESOS
Glenmark Pharmaceuticals has announced that the operations committee of the board at its meeting held on 03 January 2014 has allotted 37,500 shares to the employees of the company on exercise of options granted to them pursuant to ESOS 2003.Powered by Capital Market - Live News